Works matching IS 13520504 AND DT 2012 AND VI 19 AND IP 5

Results: 10

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 332, doi. 10.1111/j.1365-2893.2011.01553.x
By:
- Clark, P. J.;
- Thompson, A. J.;
- Zhu, M.;
- Vock, D. M.;
- Zhu, Q.;
- Ge, D.;
- Patel, K.;
- Harrison, S. A.;
- Urban, T. J.;
- Naggie, S.;
- Fellay, J.;
- Tillmann, H. L.;
- Shianna, K.;
- Noviello, S.;
- Pedicone, L. D.;
- Esteban, R.;
- Kwo, P.;
- Sulkowski, M. S.;
- Afdhal, N.;
- Albrecht, J. K.
Publication type:
Article
Neuropsychological tools in hepatology: a survival guide for the clinician.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 307, doi. 10.1111/j.1365-2893.2012.01592.x
By:
- Montagnese, S.;
- Schiff, S.;
- De Rui, M.;
- Crossey, M. M. E.;
- Amodio, P.;
- Taylor-Robinson, S. D.
Publication type:
Article
Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 353, doi. 10.1111/j.1365-2893.2011.01556.x
By:
- Lim, Y. S.;
- Shin, K. S.;
- Oh, S. H.;
- Kang, S. M.;
- Won, S. J.;
- Hwang, S. B.
Publication type:
Article
Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 327, doi. 10.1111/j.1365-2893.2011.01551.x
By:
- Che, W.;
- Liu, W.;
- Wei, Y.;
- Xu, Y.;
- Hou, L.;
- Matsumori, A.;
- Hu, D.
Publication type:
Article
Hepatitis C virus and the brain.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 301, doi. 10.1111/j.1365-2893.2012.01591.x
By:
- Fletcher, N. F.;
- McKeating, J. A.
Publication type:
Article
Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 346, doi. 10.1111/j.1365-2893.2011.01555.x
By:
- Restivo, L.;
- Zampino, R.;
- Guerrera, B.;
- Ruggiero, L.;
- Adinolfi, L. E.
Publication type:
Article
Reliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 316, doi. 10.1111/j.1365-2893.2011.01550.x
By:
- Bonner, J. E.;
- Esserman, D.;
- Evon, D. M.
Publication type:
Article
Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 341, doi. 10.1111/j.1365-2893.2011.01554.x
By:
- Stepanova, M.;
- Lam, B.;
- Younossi, Y.;
- Srishord, M. K;
- Younossi, Z. M.
Publication type:
Article
End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 371, doi. 10.1111/j.1365-2893.2011.01565.x
By:
- Aslinia, F. M.;
- Wasan, S. K.;
- Mindikoglu, A. L.;
- Adeyemo, O. A.;
- Philosophe, B.;
- Drachenberg, C.;
- Howell, C. D.
Publication type:
Article
Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems.
Published in:
Journal of Viral Hepatitis, 2012, v. 19, n. 5, p. 364, doi. 10.1111/j.1365-2893.2011.01558.x
By:
- Wu, S.-F.;
- Lin, C.-K.;
- Chuang, Y.-S.;
- Chang, F.-R.;
- Tseng, C.-K.;
- Wu, Y.-C.;
- Lee, J.-C.
Publication type:
Article